Literature DB >> 21703883

Acoustic droplet vaporization for enhancement of thermal ablation by high intensity focused ultrasound.

Man Zhang1, Mario L Fabiilli, Kevin J Haworth, Frederic Padilla, Scott D Swanson, Oliver D Kripfgans, Paul L Carson, Jeffrey Brian Fowlkes.   

Abstract

RATIONALE AND
OBJECTIVES: Acoustic droplet vaporization (ADV) shows promise for spatial control and acceleration of thermal lesion production. The investigators hypothesized that microbubbles generated by ADV could enhance high-intensity focused ultrasound (HIFU) thermal ablation by controlling and increasing local energy absorption.
MATERIALS AND METHODS: Thermal lesions were produced in tissue-mimicking phantoms using focused ultrasound (1.44 MHz) with a focal intensity of 4000 W · cm(-2) in degassed water at 37°C. The average lesion volume was measured by visible change in optical opacity and by T2-weighted magnetic resonance imaging. In addition, in vivo HIFU lesions were generated in a canine liver before and after an intravenous injection of droplets with a similar acoustic setup.
RESULTS: Thermal lesions were sevenfold larger in phantoms containing droplets (3 × 10(5) droplets/mL) compared to phantoms without droplets. The mean lesion volume with a 2-second HIFU exposure in droplet-containing phantoms was comparable to that made by a 5-second exposure in phantoms without droplets. In the in vivo study, the average lesion volumes without and with droplets were 0.017 ± 0.006 cm(3) (n = 4; 5-second exposure) and 0.265 ± 0.005 cm(3) (n = 3; 5-second exposure), respectively, a factor of 15 difference. The shape of ADV bubbles imaged with B-mode ultrasound was very similar to the actual lesion shape as measured optically and by magnetic resonance imaging.
CONCLUSION: ADV bubbles may facilitate clinical HIFU ablation by reducing treatment time or requisite in situ total acoustic power and provide ultrasonic imaging feedback of the thermal therapy.
Copyright © 2011 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703883      PMCID: PMC3152672          DOI: 10.1016/j.acra.2011.04.012

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  46 in total

1.  Modeling of high-intensity focused ultrasound-induced lesions in the presence of cavitation bubbles

Authors: 
Journal:  J Acoust Soc Am       Date:  2000-07       Impact factor: 1.840

2.  Bubble dynamics and size distributions during focused ultrasound insonation.

Authors:  Xinmai Yang; Ronald A Roy; R Glynn Holt
Journal:  J Acoust Soc Am       Date:  2004-12       Impact factor: 1.840

Review 3.  Comparison of cryoablation, radiofrequency ablation and high-intensity focused ultrasound for treating small renal tumours.

Authors:  Kyle J Weld; Jaime Landman
Journal:  BJU Int       Date:  2005-12       Impact factor: 5.588

4.  Contrast-agent-enhanced ultrasound thermal ablation.

Authors:  Yao-Sheng Tung; Hao-Li Liu; Chih-Ching Wu; Kuen-Cheng Ju; Wen-Shiang Chen; Win-Li Lin
Journal:  Ultrasound Med Biol       Date:  2006-07       Impact factor: 2.998

5.  Prostate thermal therapy with high intensity transurethral ultrasound: the impact of pelvic bone heating on treatment delivery.

Authors:  Jeffery H Wootton; Anthony B Ross; Chris J Diederich
Journal:  Int J Hyperthermia       Date:  2007-12       Impact factor: 3.914

6.  Radiofrequency ablation of small liver malignancies under magnetic resonance guidance: progress in targeting and preliminary observations with temperature monitoring.

Authors:  Sylvain Terraz; Alexandru Cernicanu; Matthieu Lepetit-Coiffé; Magalie Viallon; Rares Salomir; Gilles Mentha; Christoph D Becker
Journal:  Eur Radiol       Date:  2009-09-16       Impact factor: 5.315

7.  Temperature rise recorded during lesion formation by high-intensity focused ultrasound.

Authors:  R L Clarke; G R ter Haar
Journal:  Ultrasound Med Biol       Date:  1997       Impact factor: 2.998

8.  Proposed mechanism of pulmonary gas trapping (PGT) following intravenous perfluorocarbon emulsion administration.

Authors:  E Schutt; P Barber; T Fields; S Flaim; J Horodniak; P Keipert; R Kinner; L Kornbrust; T Leakakos; T Pelura
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  1994

9.  A NEW METHOD FOR THE GENERATION AND USE OF FOCUSED ULTRASOUND IN EXPERIMENTAL BIOLOGY.

Authors:  J G Lynn; R L Zwemer; A J Chick; A E Miller
Journal:  J Gen Physiol       Date:  1942-11-20       Impact factor: 4.086

10.  Target localization for post-prostatectomy patients using CT and ultrasound image guidance.

Authors:  Kamen Paskalev; Steven Feigenberg; Rojymon Jacob; Shawn McNeeley; Eric Horwitz; Robert Price; Charlie Ma; Alan Pollack
Journal:  J Appl Clin Med Phys       Date:  2005-11-21       Impact factor: 2.102

View more
  38 in total

1.  Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons.

Authors:  Paul S Sheeran; Samantha H Luois; Lee B Mullin; Terry O Matsunaga; Paul A Dayton
Journal:  Biomaterials       Date:  2012-01-29       Impact factor: 12.479

2.  Phase-shift perfluorocarbon agents enhance high intensity focused ultrasound thermal delivery with reduced near-field heating.

Authors:  Linsey C Phillips; Connor Puett; Paul S Sheeran; G Wilson Miller; Terry O Matsunaga; Paul A Dayton
Journal:  J Acoust Soc Am       Date:  2013-08       Impact factor: 1.840

3.  Acoustic droplet vaporization is initiated by superharmonic focusing.

Authors:  Oleksandr Shpak; Martin Verweij; Hendrik J Vos; Nico de Jong; Detlef Lohse; Michel Versluis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

4.  Acceleration of ultrasound thermal therapy by patterned acoustic droplet vaporization.

Authors:  Oliver D Kripfgans; Man Zhang; Mario L Fabiilli; Paul L Carson; Frederic Padilla; Scott D Swanson; Charles Mougenot; J Brian Fowlkes; Charles Mougenot
Journal:  J Acoust Soc Am       Date:  2014-01       Impact factor: 1.840

5.  Phase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signatures.

Authors:  Paul S Sheeran; Terry O Matsunaga; Paul A Dayton
Journal:  Phys Med Biol       Date:  2013-12-19       Impact factor: 3.609

6.  Extended Lifetime In Vivo Pulse Stimulated Ultrasound Imaging.

Authors:  James Wang; Christopher V Barback; Casey N Ta; Joi Weeks; Natalie Gude; Robert F Mattrey; Sarah L Blair; William C Trogler; Hotaik Lee; Andrew C Kummel
Journal:  IEEE Trans Med Imaging       Date:  2017-08-17       Impact factor: 10.048

7.  A pilot study to assess markers of renal damage in the rodent kidney after exposure to 7 MHz ultrasound pulse sequences designed to cause microbubble translation and disruption.

Authors:  Kennita Johnson; Rachel Cianciolo; Ryan C Gessner; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2011-11-21       Impact factor: 2.998

8.  Spatial specificity and sensitivity of passive cavitation imaging for monitoring high-intensity focused ultrasound thermal ablation in ex vivo bovine liver.

Authors:  Kevin Haworth; Vasant A Salgaonkar; Nicholas M Corregan; Christy K Holland; T D Mast
Journal:  Proc Meet Acoust       Date:  2013-06-02

9.  Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets.

Authors:  Cherry C Chen; Paul S Sheeran; Shih-Ying Wu; Oluyemi O Olumolade; Paul A Dayton; Elisa E Konofagou
Journal:  J Control Release       Date:  2013-10-02       Impact factor: 9.776

10.  Assessment of the biodistribution of an [(18) F]FDG-loaded perfluorocarbon double emulsion using dynamic micro-PET in rats.

Authors:  Mario L Fabiilli; Morand R Piert; Robert A Koeppe; Phillip S Sherman; Carole A Quesada; Oliver D Kripfgans
Journal:  Contrast Media Mol Imaging       Date:  2013 Jul-Aug       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.